White paper: The next step to automating clinical trials
Document
Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
However, there are new solutions that digitize manual processes, resulting in reduced site burden, timely kit level data for study teams, and ensuring safe delivery right to the patient.
What is on this page?
Click to jump to a specific section below.
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.
You may also be interested in
Meet us at Logipharma US in Boston on September 29th-30th
Since 2002, LogiPharma has been bringing together the top minds in life sciences and healthcare supply chain, logistics, distribution, planning, IT, quality and sourcing to share emerging best practices. This 2 -day meeting will dedicate he first day to “The Connected, Resilient and Agile Supply Chain” followed by “Supply Chain Innovation and Optimization to Support Customer Experience” on the second day. TSS is proud to present on the topic of “Using leading technology to enable harmonization of temperature management operations”.
Read moreDownload Whitepaper
How live access to GxP data support supply chain best practices?
For companies in the pharmaceutical and life sciences industry, GxP data is a critical element of supply chain best practices. Indeed, there is hardly any requirement, from visibility to synchronized logistics, which does not rely on accessing the right data.
Read moreDownload Whitepaper
Balancing Cost and Quality in the Pharmaceutical Supply Chain: A Quick Guide
In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature monitoring.
Read moreDownload WhitepaperYou may also be interested in
Meet Us at GCSG 2026 in Rome
TSS will be joining the GCSG 2026 European Knowledge Forum, taking place October 13–15 in Rome, Italy.
Read more
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more